I.ak

Pleuropneumonitis

Last update : 20/09/2015
 

Causative drugs

2

Ergots, ergot alkaloids, ergolines

I.b I - Interstitial/parenchymal lung disease
I.b - Pneumonitis (ILD)
I.d I - Interstitial/parenchymal lung disease
I.d - Organizing pneumonia (A pattern consistent with)
I.ak I - Interstitial/parenchymal lung disease
I.ak - Pleuropneumonitis
IV.a IV - Airway involvement
IV.a - Bronchospasm - Asthma
V.a V - Pleural and/or pericardial involvement
V.a - Pleural effusion
V.c V - Pleural and/or pericardial involvement
V.c - Pleural thickening/fibrosis - Fibrothorax
V.h V - Pleural and/or pericardial involvement
V.h - Chylothorax
V.m V - Pleural and/or pericardial involvement
V.m - Pleuropericardial effusion (ANA unknown or negative)
V.o V - Pleural and/or pericardial involvement
V.o - The 'folded lung' (Blesovsky syndrome)
VII.d VII - Mediastinal involvement
VII.d - Fibrosing mediastinitis
XI.u XI - Miscellaneous
XI.u - Chronic chest pain/discomfort
XI.aq XI - Miscellaneous
XI.aq - Retroperitoneal fibrosis
XII.a XII - Cardiovascular involvement / toxicity
XII.a - Left ventricular dysfunction/failure
XII.b XII - Cardiovascular involvement / toxicity
XII.b - Valvular heart disease and/or dysfunction
XII.c XII - Cardiovascular involvement / toxicity
XII.c - Pericarditis, pericardial effusion, tamponade
XII.g XII - Cardiovascular involvement / toxicity
XII.g - Myocardial ischemia, coronary artery disease, myocardial infarction
XV.ao XV - Pulmonary pathology
XV.ao - Path: Pleuritis, pleural fibrosis
XVI.an XVI - Imaging
XVI.an - Imaging: Pleural effusion
XVI.ap XVI - Imaging
XVI.ap - Imaging: Pleural thickening
4